Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

5-Hydroxytryptamine (5-HT) receptor binding was determined in intact human platelets using 125I-iodolysergic acid diethylamide (125I-iodoLSD). The assay revealed that platelets possess a single population of specific binding sites for 125I-iodoLSD which have a high affinity for the 5-HT2 receptor antagonists, ketanserin and spiperone. There was no difference in platelet 125I-iodoLSD receptor binding between depressed patients and controls. However, treatment with tricyclic antidepressants increased the number of 125I-iodoLSD receptor binding sites without significantly altering their affinity.

Type

Journal article

Journal

J Affect Disord

Publication Date

07/1987

Volume

13

Pages

45 - 50

Keywords

Adult, Antidepressive Agents, Tricyclic, Binding Sites, Blood Platelets, Depressive Disorder, Female, Humans, Iodine Radioisotopes, Male, Middle Aged, Receptors, Serotonin